Revenue segments as reported by the company.

Cannabis revenue

Distribution revenue

Beverage alcohol revenue

Wellness revenue

Adult-use

Canada - Medical

International - Medical

Bulk

Hemp

Revenue Segments

Gross Profit, Operating Income, and Net Income as a percentage of Revenue

Gross Margin

Operating Margin

Profit Margin

Margins

An operating expense is an expense a business incurs through its normal business operations. Often abbreviated as OPEX.

Impairment of Assets

Litigation settlement

Transaction costs

Change in fair value of contingent consideration

Restructuring costs

Other than temporary change in fair value of convertible notes receivable

Operating Expenses

Year over year growth in Revenue and Operating Expenses.

Revenue Y/Y

OpEx Y/Y

Growth

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company's officers and insiders.

Outstanding Shares

Market Cap

Also known as Price/Sales Ratio. Calculated using Average market cap for the quarter / Annualized quarterly revenue.

Revenue Multiple

Tilray Brands

Tilray Brands, Inc. is a global cannabis-lifestyle and consumer packaged goods company with operations in Canada, the United States, Europe, Australia, and Latin America. The firm is focused on medical cannabis research and the cultivation, processing, and distribution of cannabis products worldwide. Its products include dried cannabis and cannabis extracts. It operates through the following segments: Cannabis and Hemp. The Cannabis segment consists of adult-use, medical and bulk sales of cannabis under regulated licenses and sold to retail, wholesale, pharmacy, government, and direct to patient. The Hemp segment consists of hemp seed, hemp foods, and broad spectrum hemp extract containing CBD, which are sold in an unlicensed operation and sold to retail, wholesale and direct to consumers. The company was founded on January 24, 2018 and is headquartered in Leamington, Canada.

Earnings data Q1 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Earnings data Q1 2025

Earnings data Q2 2025

Tilray Brands reports record revenue and optimistic outlook for 2025

Tilray Brands achieved remarkable financial performance in Q4 2024, driven by strategic acquisitions and a focus on innovation. Despite challenges like price compression, the company remains optimistic about future growth opportunities. Tilray's commitment to quality products and innovation positions it well for continued success in the market.

Tilray Brands reports record Q1 revenue growth and global expansion

Tilray Brands delivered a robust performance in Q1 2025, showcasing strong revenue growth, margin improvement, and strategic expansion across its diversified product portfolio.
While facing challenges in a competitive landscape and evolving regulatory environment, Tilray's financial strength, international growth initiatives, and focus on innovation position it well for future success.
By capitalizing on opportunities in wellness products, expanding into new beverage categories, and leveraging strategic partnerships, Tilray is poised for continued growth and market leadership.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Tilray Brands, Inc. is a global cannabis-lifestyle and consumer packaged goods company, which focuses on medical cannabis research and the cultivation, processing, and distribution of cannabis products worldwide. It operates through the followings segments: Cannabis Business, Distribution Business, Beverage Alcohol Business, and Wellness Business. The Cannabis Business segment focuses on cultivation, production, distribution, and sale of both medical and adult-use cannabis products. The Distribution Business segment is involved in purchase, resale, and distribution of pharmaceutical and wellness products. The Beverage Alcohol Business segment refers to the production, marketing, and sale of beverages. The Wellness Business segment represents the production, marketing, and distribution of hemp-based food and other wellness products. The company was founded on January 24, 2018 and is headquartered in Leamington, Canada.

Aphria

Tilray Inc. shareholders voted to approve the Canadian cannabis company's proposed merger with Aphria Inc. at a special meeting on Friday, according to media reports, paving the way for the creation of the world's biggest cannabis company measured by revenue. The move was widely expected after Aphria shareholders voted in favor of a deal by a wide margin, with a total of 99.38% of shares voted approving it on April 14.

Tilray shareholders approve Aphria merger, creating world's biggest cannabis company by revenue

HEXO Corp

FSD Pharma

Akerna Corp

Philip Morris

SNDL Inc.

22nd Century Group

cbdMD Inc

Pyxus International Inc

Welcome back to our weekly series, Schaeffer's Cannabis Stock News Update, where we recap what happened in the world of marijuana stocks last week, and look ahead to how the cannabis industry will continue to develop in 2021.

These 10 Pot Stocks Smoked the Last Week of April

Expect the Tilray-Aphria merger to be approved on April 30. But TLRY stock will likely fall once the merger goes through since it may take time for synergies to work.

Tilray Stock Will Fall Following the Aphria Merger on April 30

Canopy Growth

Today, cannabis stocks are taking off as enthusiasm appears to be building in this hyper-growth segment of the market once again. The post Cannabis Stocks: Why HEXO, TLRY, APHA, CGC Stocks Gained Today appeared first on InvestorPlace.

Cannabis Stocks: Why HEXO, TLRY, APHA, CGC Stocks Gained Today

Aurora Cannabis

Cronos Group

How to approach and invest in the cannabis industry the Foolish way.

Investing in Cannabis Stocks? Check Out This Podcast.

Shares of cannabis companies such as Tilray, Inc. (NASDAQ:TLRY) and Canopy Growth Corporation (NASDAQ:CGC) are trading higher after BofA Securities reinstated a Buy rating on the stocks. BofA Securities analyst Heather Balsky reinstated a Buy rating on Tilray's stock with a $23 price target, while Canopy Growth received a $36 price target.

Why Tilray And Canopy Growth Are Trading Higher Today

Valuation multiples for cannabis stocks are likely to expand over the next year as the U.S. government reaches milestones on the path to federal cannabis legalization, according to BofA Securities. The Cannabis Analyst: Heather Balsky reinstated coverage of four cannabis stocks in separate notes:

BofA On Cannabis Stocks: Bullish On Tilray, Canopy Growth, Bearish On Cronos

OrganiGram Holdings Inc.

Looking for cannabis exposure? These seven weed stocks based in Canada could provide some explosive growth to portfolios over time.

7 Marijuana Stocks to Buy As Canada's Consumption Continues to Rise

It would be fair to say that cannabis stocks received three positive indicators over the past six months.

BofA Analysts Say These Are the 2 Weed Stocks to Buy

Village Farms International

Top Picks In 2021 For Canadian Cannabis Stocks The post Top Canadian Marijuana Stocks For Your Portfolio In 2021 appeared first on Marijuana Stocks | Cannabis Investments and News. Roots of a Budding Industry.™.

Top Canadian Marijuana Stocks For Your Portfolio In 2021

As New York's recreational cannabis industry shapes up, a group of individuals will play a big role in shaping the market's future. The Empire State legalized cannabis on March 31. More regulations and details are expected in the coming months as members are appointed to the Office of Cannabis Management and Cannabis Control Board — the regulatory bodies responsible for the industry.

See the power players shaping the future of New York's $7 billion cannabis industry

TLRY Stock is highly overvalued with a growth runway that cannot justify its post-merger valuation with Aphria The post Tilray Stock Has Valuation Problems That a Merger Just Won't Solve appeared first on InvestorPlace. More From InvestorPlace Why Everyone Is Investing in 5G All WRONG It doesn't matter if you have $500 in savings or $5 million.

Tilray Stock Has Valuation Problems That a Merger Just Won't Solve

NANAIMO, British Columbia--(BUSINESS WIRE)--Tilray, Inc. (NASDAQ: TLRY), a global pioneer in cannabis research, cultivation, production, and distribution, today announced that the company has been included in the inaugural list of TIME's 100 Most Influential Companies. The new list — an expansion of the annual TIME100 franchise — highlights 100 businesses making an extraordinary impact around the world. Brendan Kennedy, Tilray's Chief Executive Officer, said, “On behalf of every Tilray employee

Tilray Named to Time's Inaugural List of the Time100 Most Influential Companies

These cannabis producers already have a presence south of the border.

4 Canadian Cannabis Companies Poised to Profit from U.S. Legalization

Curaleaf Holdings, Inc.

Green Thumb Industries Inc.

Will it be déjà vu for investors, or is marijuana reform really on its way?

This Upcoming Catalyst Could Send Marijuana Stocks Soaring

Aphria's dismal Q2 results show that the cannabis sector hasn't overcome its structural challenges, while U.S. legalization is unlikely. Investors should sell APHA stock.

The Tilray Merger Won't Make Aphria Stock Any More Appealing

The Tilray-Aphria merger looks intriguing on its face. But soft earnings and questions about the combined company make APHA stock an avoid.

Aphria Stock Looks Like a Hard Pass Ahead of the Tilray Merger

Amplify Alternative Harvest ETF

Altria

Constellation Brands

Marijuana stocks have been hot and cold for years. Coming off a strong stretch, investors hope the group -- including these seven marijuana stocks -- can find its footing and go higher.

7 Marijuana Stocks To Buy As Usage Moves Mainstream

Arena Pharmaceuticals

Corbus Pharmaceuticals Holdings

GW Pharmaceuticals

Innovative Industrial Properties

Jazz Pharmaceuticals

Neptune Wellness Solutions Inc.

Turning Point Brands

Welcome back to our weekly series, Schaeffer's Cannabis Stock News Update, where we recap what happened in the world of marijuana stocks last week, and look ahead to how the cannabis industry will continue to develop in the 2021.

4/20 Holiday Week Had These Cannabis Stocks Fired Up

JD.com

Simon Property Group

On the hunt for bargains? Here's how these three stocks can add muscle to your portfolio.

3 Extremely Undervalued Stocks to Buy Now

Trulieve Cannabis Corp.

The sector has been red-hot this past year, and even mediocre stocks have done well.

Are Canadian Pot Stocks Headed for Another Crash?

Tilray and Aphria are set to merge into the largest cannabis company. The advantages of this size and strength could make TLRY stock a long-term multi-bagger.

Tilray Stock Is Still the King Among Cannabis Investments

GrowGeneration Corp

Where To Invest in Marijuana Stocks Canadian Vs U.S. The post Best Cannabis Stocks To Buy Right Now? 2 To Watch In April appeared first on Marijuana Stocks | Cannabis Investments and News. Roots of a Budding Industry.™.

Best Cannabis Stocks To Buy Right Now? 2 To Watch In April

Sundial Growers Inc. (NASDAQ:SNDL) and Tilray Inc. (NASDAQ:TLRY) stock lost ground Tuesday. The cannabis stocks jumped Monday following the passage of the SAFE Banking Act in the House of Representatives and are now making a correction.

2 Pot Stocks Looking To Find Support

In the wake of this marijuana holiday's inevitable festivities, the US house of representatives passed the SAFE Banking Act, which would give US marijuana companies access to funding from federally insured banks.

Marijuana Stocks To Consider Before Celebrating 420

News for Tilray Brands Stock (TLRY)